Idera Pharmaceuticals Inc IDRA:NASDAQ

Last Price$0.44NASDAQ Previous Close - Last Trade as of 4:00PM ET 7/01/22

Today's Change0(0.00%)
Bid (Size)$0.44 (4)
Ask (Size)$0.49 (127)
Day Low / HighN/A - N/A
Volume83.5 K

View Biotechnology IndustryPeer Comparison as of 07/01/2022


Idera Pharmaceuticals Inc ( NASDAQ )

Price: $0.44
Change: -0.02 (4.58%)
Volume: 83.5 K
4:00PM ET 7/01/2022

Eloxx Pharmaceuticals Inc ( NASDAQ )

Price: $0.25
Change: -0.02 (7.30%)
Volume: 123.0 K
4:00PM ET 7/01/2022

Soligenix Inc ( NASDAQ )

Price: $0.58
Change: -0.02 (3.20%)
Volume: 67.5 K
4:00PM ET 7/01/2022

BioCardia Inc ( NASDAQ )

Price: $1.46
Change: +0.01 (0.69%)
Volume: 37.7 K
4:00PM ET 7/01/2022

India Globalization Capital Inc ( NYSE MKT LLC )

Price: $0.51
Change: -0.02 (3.77%)
Volume: 221.0 K
8:00PM ET 7/01/2022

Read more news Recent News

Top Premarket Decliners
8:08AM ET 6/03/2022 MT Newswires

Bit Origin (BTOG) shares slumped 40% after the company initiated a public offering of common stock. TC Biopharm (TCBP) shares tumbled 35% after the company...

Idera Halts Enrollment in Mid-Stage Trial for Tilsotolimod in Melanoma Patients After Meeting Primary Endpoint
9:34AM ET 5/17/2022 MT Newswires

Idera Pharmaceuticals (IDRA) said Tuesday that it has halted enrollment in a mid-stage clinical trial for its toll-like receptor 9 agonist tilsotolimod in...

View all Commentary and Analysis

No news stories available at this time.

Company Profile

Business DescriptionIdera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. View company web site for more details
Address505 Eagleview Boulevard
Exton, Pennsylvania 19341
Number of Employees36
Recent SEC Filing07/01/2022SC 13D/A
President, Chief Executive Officer & DirectorVin Milano
Chief Operating Officer & Senior Vice PresidentDon Soland
Chief Financial Officer & Senior Vice PresidentJohn J. Kirby
Secretary, Senior VP & General CounselBryant Lim

Company Highlights

Price Open$0.43
Previous Close$0.46
52 Week Range$0.30 - 1.22
Market Capitalization$23.2 M
Shares Outstanding53.0 M
SectorHealth Technology
Next Earnings Announcement08/08/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.42
Beta vs. S&P 500N/A
Revenue$662.0 K
Net Profit MarginN/A
Return on Equity-69.27%

Analyst Ratings as of 06/26/2021

Consensus RecommendationConsensus Icon
Powered by Factset